248 related articles for article (PubMed ID: 15897582)
21. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
22. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
[TBL] [Abstract][Full Text] [Related]
23. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of HSV mass distribution in a rodent brain tumor model.
Schellingerhout D; Rainov NG; Breakefield XO; Weissleder R
Gene Ther; 2000 Oct; 7(19):1648-55. PubMed ID: 11083473
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
[TBL] [Abstract][Full Text] [Related]
26. Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells.
Jin CH; Kusuhara K; Yonemitsu Y; Nomura A; Okano S; Takeshita H; Hasegawa M; Sueishi K; Hara T
Gene Ther; 2003 Feb; 10(3):272-7. PubMed ID: 12571635
[TBL] [Abstract][Full Text] [Related]
27. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats.
Alves A; Charre L; Panis Y; Cardoso J; Fabre M; Brisson E; Houssin D; Soubrane O; Klatzmann D
Surgery; 2003 Jun; 133(6):669-77. PubMed ID: 12796736
[TBL] [Abstract][Full Text] [Related]
28. Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils.
Shirakura M; Inoue M; Fujikawa S; Washizawa K; Komaba S; Maeda M; Watabe K; Yoshikawa Y; Hasegawa M
Gene Ther; 2004 May; 11(9):784-90. PubMed ID: 14961067
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
Rainov NG; Dobberstein KU; Heidecke V; Dorant U; Chase M; Kramm CM; Chiocca EA; Breakefield XO
Cancer Gene Ther; 1998; 5(3):158-62. PubMed ID: 9622099
[TBL] [Abstract][Full Text] [Related]
30. Sendai virus transgene in a novel gene therapy for laryngotracheal disease.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Inoue M; Hasegawa M; Shiotani A
Laryngoscope; 2013 Jul; 123(7):1717-24. PubMed ID: 23666749
[TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector.
Shiotani A; Fukumura M; Maeda M; Hou X; Inoue M; Kanamori T; Komaba S; Washizawa K; Fujikawa S; Yamamoto T; Kadono C; Watabe K; Fukuda H; Saito K; Sakai Y; Nagai Y; Kanzaki J; Hasegawa M
Gene Ther; 2001 Jul; 8(14):1043-50. PubMed ID: 11526451
[TBL] [Abstract][Full Text] [Related]
32. Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies.
Kinoh H; Inoue M; Komaru A; Ueda Y; Hasegawa M; Yonemitsu Y
Gene Ther; 2009 Mar; 16(3):392-403. PubMed ID: 19037241
[TBL] [Abstract][Full Text] [Related]
33. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
[TBL] [Abstract][Full Text] [Related]
34. Validation of recombinant Sendai virus in a non-natural host model.
Griesenbach U; McLachlan G; Owaki T; Somerton L; Shu T; Baker A; Tennant P; Gordon C; Vrettou C; Baker E; Collie DD; Hasegawa M; Alton EW
Gene Ther; 2011 Feb; 18(2):182-8. PubMed ID: 20962870
[TBL] [Abstract][Full Text] [Related]
35. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
36. Recombinant Sendai virus vectors for activated T lymphocytes.
Okano S; Yonemitsu Y; Nagata S; Sata S; Onimaru M; Nakagawa K; Tomita Y; Kishihara K; Hashimoto S; Nakashima Y; Sugimachi K; Hasegawa M; Sueishi K
Gene Ther; 2003 Aug; 10(16):1381-91. PubMed ID: 12883535
[TBL] [Abstract][Full Text] [Related]
37. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
[TBL] [Abstract][Full Text] [Related]
38. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.
Yang WQ; Lun X; Palmer CA; Wilcox ME; Muzik H; Shi ZQ; Dyck R; Coffey M; Thompson B; Hamilton M; Nishikawa SG; Brasher PM; Fonseca K; George D; Rewcastle NB; Johnston RN; Stewart D; Lee PW; Senger DL; Forsyth PA
Clin Cancer Res; 2004 Dec; 10(24):8561-76. PubMed ID: 15623640
[TBL] [Abstract][Full Text] [Related]
40. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
